Main Article Content
Aims: The aim of this study is to find out the prevalence of benign breast lesions and proliferative lesions which are associated with increase risk of breast cancer. This is aimed at influencing the hospital policy on mammographic screening.
Study Design: Descriptive retrospective study involving a trend analysis of benign breast lesion, proliferative analysed in the surgical pathology unit of the University of Calabar Teaching Hospital between 1st of January 2012 to October 31st 2014.
Place and Duration of Study: Pathology Department of the University of Calabar Teaching Hospital. The study was carried out between March and April 2019.
Methodology: Descriptive retrospective study of trend analysis of benign and proliferative breast lesions over the period with literature review.
Results: Two hundred and seventeen 217 patients consisting of seven males and two hundred and ten females with a female: Male ratio of 1:0.04. Mean age was 26.4 ± 10.0 years, ranging from 10 to 70 years, with 21-30 (94, 43.5%), as the predominant age and less than 21 years (70, 32.4%) as the second common age group. Seventy four percent of (74%) of the breast lesions were benign non proliferative lesions while 26% were proliferative breast lesions. Of the proliferative lesions, five or 8.9% of the proliferative or 2.33% of the lesions were atypical ductal hyperplasia’s which have a high risk of progression to cancer.
Conclusion: Proliferative breast lesions and the premalignant lesions of the breast are not commonly reported in Calabar. An upscale of population screening and mammographic services may improve their yield which will help prevent some invasive breast cancers.
Anyanwu LJ, Anyanwu OM, Yakubu AA. Missed opportunities for breast awareness information among women attending the maternal and child health services of an urban tertiary hospital in Northern Nigeria. J Cancer Res Ther. 2016;12(2):765-9.
Ikeri NZ, Oguntunde OA, Igbokwe U, Abdulkareem FB, Banjo AA. Breast cancer in a Lagos facility: Implications for the institution of a cancer screening programme. Pathobiology. 2018;85(4):254-60.
Anakwenze C, Bhatia R, Rate W, Bakwenabatsile L, Ngoni K, Rayne S, et al. Factors related to advanced stage of cancer presentation in Botswana. J Glob Oncol. 2018;4:1-9.
Adeniji KA, Adelusola KA, Odesanmi WO. Benign disease of the breast in Ile-Ife: A 10 year experience and literature review. Cent Afr J Med. 1997;43(5):140-3.
Adesunkanmi AR, Agbakwuru EA. Benign breast disease at Wesley Guild Hospital, Ilesha, Nigeria. West Afr J Med. 2001;20(2):146-51.
Ajao OG. Benign breast lesions. J Natl Med Assoc. 1979;71(9):867-8.
Anyikam A, Nzegwu MA, Ozumba BC, Okoye I, Olusina DB. Benign breast lesions in Eastern Nigeria. Saudi Med J. 2008;29(2):241-4.
Ibitoye BO, Adetiloye VA, Aremu AA. The appearances of benign breast diseases on ultrasound. Niger J Med. 2006;15(4):421-6.
Ihekwaba FN. Benign breast disease in Nigerian women: A study of 657 patients. J R Coll Surg Edinb. 1994;39(5):280-3.
Kathcy KC, Datubo-Brown DD, Gogo-Abite M, Iweha UU. Benign breast lesions in Nigerian women in Rivers State. East Afr Med J. 1990;67(3):201-4.
Olu-Eddo AN, Ugiagbe EE. Benign breast lesions in an African population: A 25-year histopathological review of 1864 cases. Niger Med J. 2011;52(4):211-6.
Osime OC, Ohanaka EC. Analysis of five-year breast biopsies carried out in the University of Benin Teaching Hospital Benin City. Niger Postgrad Med J. 2008;15(3):160-3.
Otu AA. Benign breast tumours in an African population. J R Coll Surg Edinb. 1990;35(6):373-5.
Okoth C, Galukande M, Jombwe J, Wamala D. Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: A cross sectional study. BMC Surg. 2013;13:9.
Chaudhuri M, Sen S, Sengupta J. Breast lumps: A study of 10 years. J Indian Med Assoc. 1995;93(12):455-7.
Burnett SJ, Ng YY, Perry NM, Gilmore OJ, Allum WH, Carpenter R, et al. Benign biopsies in the prevalent round of breast screening: A review of 137 cases. Clin Radiol. 1995;50(4):254-8.
Amin TT, Al-Mulhim AR, Chopra R. Histopathological patterns of female breast lesions at secondary level care in Saudi Arabia. Asian Pac J Cancer Prev. 2009;10(6):1121-6.
Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, et al. Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Prev Res (Phila). 2012;5(12):1375-80.
Dorjgochoo T, Deming SL, Gao YT, Lu W, Zheng Y, Ruan Z, et al. History of benign breast disease and risk of breast cancer among women in China: A case-control study. Cancer Causes Control. 2008;19(8): 819-28.
Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258-65.
Dyrstad SW, Yan Y, Fowler AM, Colditz GA. Breast cancer risk associated with benign breast disease: Systematic review and meta-analysis. Breast Cancer Res Treat. 2015;149(3):569-75.
Ferrara A. Benign breast disease. Radiol Technol. 2011;82(5):447M-62M.
Ben Hassouna J, Damak T, Ben Slama A, Chargui R, Ben Dhiab T, Khomsi F, et al. Breast carcinoma arising within fibroadenomas. Report of four observations. Tunis Med. 2007;85(10):891-5.
Cheng J, Qiu S, Raju U, Wolman SR, Worsham MJ. Benign breast disease heterogeneity: Association with histopatho-logy, age, and ethnicity. Breast Cancer Res Treat. 2008;111(2):289-96.
Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, et al. Ductal epithelial proliferations of the breast: A biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol. 2001;195(4):415-21.
Boecker W, Moll R, Dervan P, Buerger H, Poremba C, Diallo RI, et al. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. J Pathol. 2002;198(4): 458-67.
Chinoy RF. Proliferative lesions of the breast: Carcinoma in situ. Indian J Pathol Microbiol. 2003;46(2):153-64.
Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies. Cancer. 2016;122(4):515-20.
Anastasiadis P, Romanidis K, Polychronidis A, Koutlaki N, Tamiolakis D, Simopoulos K. Proliferative breast disease: Epidemiologic aspects, and cytologic diagnosis. Eur J Gynaecol Oncol. 2003;24(6):547-51.
Page D, William Dupoint, Lowell W. Rogers, Margaret S. Rados. . Cancer. 1985;55:2698-708.
Mayun AA, Pindiga UH, Babayo UD. Pattern of histopathological diagnosis of breast lesions in Gombe, Nigeria. Niger J Med. 2008;17(2):159-62.
Oluwole SF, Freeman HP. Analysis of benign breast lesions in blacks. Am J Surg. 1979;137(6):786-9.
Onukak EE, Cederquist RA. Benign breast disorders in nonwestern populations: Part III--Benign breast disorders in Northern Nigeria. World J Surg. 1989;13(6):750- 2.
Uwaezuoke SC, Udoye EP. Benign breast lesions in Bayelsa State, Niger Delta Nigeria: A 5 year multicentre histopathological audit. Pan Afr Med J. 2014;19:394.
Ozumba BC, Nzegwu MA, Anyikam A, Okoye I, Okafor OC. Breast disease in children and adolescents in eastern Nigeria--a five-year study. J Pediatr Adolesc Gynecol. 2009;22(3):169-72.
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229-37.
Egwuonwu OA, Anyanwu S, Chianakwana GU, Ihekwoaba EC. Fibroadenoma: Accuracy of clinical diagnosis in females aged 25 years or less. Niger J Clin Pract. 2016;19(3):336-8.
Elsheikh A, Keramopoulos A, Lazaris D, Ambela C, Louvrou N, Michalas S. Breast tumors during adolescence. Eur J Gynaecol Oncol. 2000;21(4):408-10.
Duflos C, Plu-Bureau G, Thibaud E, Kuttenn F. Breast diseases in adolescents. Endocr Dev. 2012;22:208-21.
Worsham MJ, Raju U, Lu M, Kapke A, Botttrell A, Cheng J, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009;118(1):1-7.
Moskowitz M, Gartside P, Wirman JA, McLaughlin C. Proliferative disorders of the breast as risk factors for breast cancer in a self-selected screened population: patho-logic markers. Radiology. 1980;134(2): 289-91.
Pettinato G, Panico L, de Rosa N, D'Antonio A, Bifano D, Avallone M. Benign lesions of the breast. Ann Ital Chir. 1997;68(2):151-66.
Myhre E. Is fibrocystic breast disease a pre-malignant state? Acta Obstet Gynecol Scand Suppl. 1984;123:189-91.
McFarlane ME. Benign breast diseases in an Afro-Caribbean population. East Afr Med J. 2001;78(7):358-9.
Schnitt SJ. Benign breast disease and breast cancer risk: Morphology and beyond. Am J Surg Pathol. 2003;27(6): 836-41.
Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer. 1988;61(10): 2077-82.
Salamat FM, Niakan BM, Keshtkar AP, Rafiei EM, Zendehdel MM. Subtypes of benign breast disease as a risk factor of breast cancer: A systematic review and meta analyses. Iran J Med Sci. 2018;43(4):355-64.